5-methylcytosine has been researched along with Benign Neoplasms in 118 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (5.08) | 18.7374 |
1990's | 22 (18.64) | 18.2507 |
2000's | 10 (8.47) | 29.6817 |
2010's | 63 (53.39) | 24.3611 |
2020's | 17 (14.41) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Hou, P; Li, K; Su, J; Sun, J; Wang, Y; Yan, C; Zhao, J; Zhou, M | 1 |
Li, Y; Liu, Y; Ma, C; Seong, H; Xu, S; Yu, X | 1 |
Cheng, X; Li, Q; Liu, T; Wang, J | 1 |
Besaratinia, A; Caceres, A; Tommasi, S | 1 |
Lu, MJ; Lu, Y | 1 |
Bao, Z; Chu, Q; Jiang, S; Li, L; Lu, J; Su, Y; Xue, C; Zheng, Q | 1 |
Hu, J; Li, DL; Qiu, JG; Wang, ZY; Yuan, H; Zhang, CY | 1 |
An, J; Ko, M | 1 |
Bettegowda, C; Cohen, JD; Curtis, S; Dobbyn, L; Douville, C; Dudley, JC; Ho-Pham, LT; Kinzler, KW; Mattox, A; Nehme, N; Nguyen, TV; Papadopoulos, N; Popoli, M; Ptak, J; Silliman, N; Summers, M; Tran, BNH; Tran, TS; Vogelstein, B; Wang, Y; Zhang, M | 1 |
An, J; Jung, I; Kim, H; Ko, M; Lee, CH | 1 |
Skvortsova, K; Stirzaker, C; Taberlay, P | 1 |
Gao, H; Xu, T | 1 |
Andreou, AZ; Kouidou, S; Malousi, A | 1 |
Blanco, S; Miguel-López, B; Nombela, P | 1 |
Bray, JK; Dawlaty, MM; Maitra, A; Verma, A | 1 |
Fang, J; Gao, Y | 1 |
Guo, W; He, Y; Yu, X; Zhang, M | 1 |
Fernández, AF; Fraga, MF; López, V | 1 |
Olivier, J; Poulos, RC; Wong, JWH | 1 |
Chen, Y; Chua, MS; Diao, J; Dong, B; Hu, J; Jeffrey, SS; Li, W; Liu, B; Ma, L; Quake, SR; So, S; Song, CX; Tian, Z; Wei, Y; Wheeler, A; Xie, D; Xiong, J; Yin, S; Zhang, W; Zhang, Y; Zhou, Z | 1 |
Adhikari, S; Bissonnette, MB; Chen, G; Cui, M; Dai, M; Dong, Y; Hao, H; He, C; Hong, J; Hua, L; Jia, G; Li, W; Liao, Q; Liu, J; Liu, Z; Lu, X; Luo, F; Luo, Z; Meckel, K; Nie, J; Qian, X; Shi, J; Song, Y; Wang, P; Wang, Y; Wei, L; Xu, D; You, L; Yu, S; Yuan, F; Zhang, J; Zhang, T; Zhang, W; Zhang, X; Zhao, Y; Zheng, W | 1 |
Cavalcante, RG; Park, Y; Patil, S; Rozek, LS; Sartor, MA | 1 |
Kriaucionis, S; McClellan, M; Schuster-Böckler, B; Tomkova, M | 1 |
Cech, TR; Costello, JC; Ghandi, M; Huang, FW; Nwumeh, R; Paucek, RD; Stern, JL | 1 |
Aguilar, S; Argilés, G; Arqués, O; Arroyo, AG; Caratù, G; Casanovas, O; Chicote, I; Cuesta-Borrás, E; Dienstmann, R; Eguizabal, C; Gonzalo, P; Landolfi, S; Martínez-Quintanilla, J; Nuciforo, P; Palmer, HG; Prat, A; Puig, I; Ramírez, L; Recio, JA; Seoane, J; Serra, V; Soto, A; Tabernero, J; Tenbaum, SP; Terracciano, L; Villanueva, A; Vivancos, A | 1 |
Adler, GK; Argueta, C; Chen, H; Chen, J; Dong, Z; Duquette, D; Fan, J; Fang, R; Fetahu, IS; Garg, R; Geng, S; Hu, D; Lan, F; Li, Y; Lian, CG; Liu, H; Lv, R; Lynch, L; Mao, F; Murphy, GF; Rabidou, K; Shi, G; Shi, Y; Shi, YG; Tan, L; Wang, M; Wu, D; Wu, F; Xu, S; Xu, Y; Yan, G; Yang, P; Ye, Y; Yin, C; Zhang, L; Zhang, S | 1 |
Pfeifer, GP; Szabó, PE | 1 |
Harjes, U | 1 |
Ecker, JR; Hajkova, P; Luo, C | 1 |
Krais, AM; Meister, M; Park, YJ; Plass, C; Reifenberger, G; Schmeiser, HH | 1 |
Bogdanovic, O; Clark, SJ; Colino-Sanguino, Y; Du, Q; Goodnow, CC; Gould, CM; Horvath, L; Kench, JG; Khoury, A; Lim, SM; Luu, PL; Masle-Farquhar, E; Miosge, LA; Nair, SS; Peters, TJ; Pidsley, R; Polo, JM; Qu, W; Reed, JH; Rubin, MA; Skvortsova, K; Smith, GC; Song, JZ; Stirzaker, C; Zotenko, E | 1 |
Chiu, BC; Stroup, EK; Zeng, C; Zhang, W; Zhang, Z | 1 |
Benner, A; Slynko, A | 1 |
Avraham, S; Caspi, M; Ebenstein, Y; Friedmann-Morvinski, D; Gilat, N; Kariv, R; Lahat, G; Loewenstein, S; Magod, P; Margalit, S; Michaeli, Y; Rosin-Arbesfeld, R; Shahal, T; Zirkin, S | 1 |
De Marzo, AM; Ghosh, S; Haffner, MC; Lotan, TL; Nelson, WG; Pellakuru, LG; Yegnasubramanian, S | 1 |
Błasiak, J; Głowacki, S | 1 |
Wyatt, MD | 1 |
Cadet, J; Wagner, JR | 1 |
Kohli, RM; Zhang, Y | 1 |
Li, L; Ye, C | 1 |
Harrison, DJ; Laird, A; Meehan, RR; Thomson, JP | 1 |
Ling, ZQ; Wu, YC | 1 |
Barciszewska, AM; Naskręt-Barciszewska, MZ; Nowak, S | 1 |
Hahn, MA; Jin, SG; Pfeifer, GP; Xiong, W | 1 |
Delatte, B; Deplus, R; Fuks, F | 1 |
He, C; Shen, L; Song, CX; Zhang, Y | 1 |
Asande, M; Candeloro, P; Cojoc, G; Coluccio, ML; De Vitis, S; Di Fabrizio, E; Limongi, T; Malara, N; Mollace, V; Perozziello, G; Prati, U; Raimondo, R; Raso, C; Renne, M; Roveda, L; Trunzo, V | 1 |
Arab, K; Dienemann, H; Dyckhoff, G; Grummt, I; Herold-Mende, C; Lindroth, AM; Lukanova, A; Lundin, E; Meister, M; Niehrs, C; Oakes, C; Park, YJ; Plass, C; Risch, A; Schäfer, A; Weichenhan, D | 1 |
Huang, Y; Rao, A | 1 |
Chen, T; Chen, Y; Frank, MY; Guo, W; Lian, CG; Liu, C; Liu, R; Murphy, GF; Xu, S; Yan, J | 1 |
Ficz, G; Gribben, JG | 1 |
Chatterjee, A; Morison, IM; Rodger, EJ | 1 |
Cho, IH; Chowdhury, B; Hahn, N; Irudayaraj, J | 1 |
Chen, HF; Chen, SY; Cheng, WC; He, C; Shen, ZJ; Song, C; Teng, SC; Tsai, YP; Wang, HW; Wu, KJ | 1 |
Jansen, JH; Kroeze, LI; van der Reijden, BA | 1 |
Sehgal, M; Shukla, A; Singh, TR | 1 |
Godley, LA; Vasanthakumar, A | 1 |
Berridge, G; Goldin, R; Kessler, BM; Kriaucionis, S; Pugh, KM; Thézénas, ML; Zauri, M | 1 |
Ehrlich, M | 1 |
Barry, WT; Beroukhim, R; Birkbak, NJ; Clark, AP; Culhane, AC; Eklund, AC; Hill, DE; Landini, S; Lim, E; Neupane, M; Schumacher, SE; Silver, DP; Szallasi, Z; Vidal, M | 1 |
Ciesielski, P; Jóźwiak, P; Krześlak, A | 1 |
Collignon, E; Fuks, F; Jeschke, J | 1 |
Bi, C; Cai, B; Liang, J; Yang, F; Zhao, L | 1 |
Jin, WL; Li, WB; Lian, H | 1 |
Du, Q; Guo, H; Hu, Z; Liang, D; Song, W; Wang, H; Xiong, X; Yang, Z; Ye, M; Zhai, S; Zhang, LH; Zhang, X | 1 |
Feinberg, A; Hansen, KD; Li, X; Liu, Y; Salz, T | 1 |
Bhoopatiraju, S; Forster, CL; Freeman, MJ; Hallstrom, TC; Linden, MA; Lu, H; Schmitz, NP; Verneris, MR; Wang, H; Wang, X | 1 |
Chen, Z; Guo, L; He, J; Li, Y; Luo, M; Shi, X | 1 |
Meehan, RR; Thomson, JP | 1 |
Baylin, SB; Cai, Y; Easwaran, H; Li, Y; Luo, J; Wang, Z; Xia, L; Xie, W; Yen, RC; Zhang, YW | 1 |
Carell, T; Globisch, D; Münzel, M | 1 |
Barciszewski, J; Giel-Pietraszuk, M; Markiewicz, WT; Plitta, B | 1 |
Jiang, Y; Jin, SG; Krex, D; Lu, Q; Pfeifer, GP; Qiu, R; Rauch, TA; Schackert, G; Wang, Y | 1 |
Egger, G; Kriegner, A; Pulverer, W; Weinhäusel, A; Wielscher, M | 1 |
Aburatani, H; Asaoka, Y; Ijichi, H; Koike, K; Kudo, Y; Nagae, G; Tateishi, K; Yamamoto, K; Yamamoto, S; Yoshida, H | 1 |
Bai, F; Guan, KL; Ling, ZQ; Liu, J; Liu, Y; Ma, SH; Xiong, Y; Xu, ZD; Yang, H; Ye, D; Zhang, JY; Zhu, HG | 1 |
Shi, YG; Tan, L | 1 |
Guz, J; Jurgowiak, M; Oliński, R | 1 |
Jones, PA; You, JS | 1 |
Kinney, SR; Pradhan, S | 1 |
Avila, S; Capella, G; Esteller, M; Fraga, MF; Herman, JG; Paz, MF; Peinado, MA; Pollan, M; Sanchez-Cespedes, M | 1 |
Johanning, GL; Piyathilake, CJ | 1 |
Avila, S; Esteller, M; Fraga, MF; Guo, M; Herman, JG; Paz, MF; Pollan, M | 1 |
Ballestar, E; Cigudosa, JC; Espada, J; Esteller, M; Fraga, MF; Huang, TH; Paz, MF; Valle, L; Wei, S | 1 |
Dueñas-Gonzalez, A; Revilla Vázquez, A; Sandoval Guerrero, K; Segura-Pacheco, B | 1 |
Walsh, CP; Xu, GL | 1 |
Akhoondi, S; Apostolidou, S; Cepeda, D; Corcoran, M; Dafou, D; Dagnell, M; Dofou, D; Egyhazi, S; Fiegl, H; Grander, D; Hansson, J; Klotz, K; Maljukova, A; Marth, C; Mueller-Holzner, E; Nayer, BN; Nejad, SZ; Nordgren, H; Petersson, F; Reed, SI; Sangfelt, O; Sangfelt, P; Spruck, C; Sun, D; von der Lehr, N; Widschwendter, M; Zali, MR | 1 |
Jones, PA; Riggs, AD | 1 |
Ehrlich, M; Gama-Sosa, MA; Gehrke, CW; Kuo, KC; Oxenhandler, R; Slagel, VA; Trewyn, RW | 1 |
Magee, PN; Nyce, J; Weinhouse, S | 1 |
Cheah, MS; Diala, ES; Hoffman, RM; Rowitch, D | 1 |
Bogenmann, E; Flatau, E; Jones, PA | 1 |
Bhagwat, AS; Yebra, MJ | 1 |
Little, M; Wainwright, B | 1 |
Baylin, SB; Burger, PC; Gabrielson, E; Herman, JG; Lee, DJ; Mao, L; Merlo, A; Sidransky, D | 1 |
Grigg, GW; Holliday, R | 1 |
Counts, JL; Goodman, JI | 1 |
Hennig, UG; von Borstel, RC | 1 |
Jones, PA; Rideout, WM; Spruck, CH | 1 |
Harris, CC | 1 |
Heby, O | 1 |
Jones, PA | 1 |
Venitt, S | 1 |
Bird, AP | 1 |
Gonzalgo, ML; Jones, PA | 2 |
Wachsman, JT | 1 |
Jones, PA; Zingg, JM | 1 |
Laird, PW | 1 |
Holmquist, GP; Pfeifer, GP | 1 |
Jones, PA; Robertson, KD | 2 |
Denissenko, MF; Pfeifer, GP | 1 |
Issa, JP; Kantarjian, HM; Santini, V | 1 |
Costello, JF; Plass, C | 1 |
Jones, PA; Rideout, WM; Shen, JC; Spruck, CH; Tsai, YC | 1 |
Coetzee, GA; Jones, PA; Olumi, AF; Rideout, WM; Spruck, CH | 1 |
Chandler, LA; Jones, PA | 1 |
66 review(s) available for 5-methylcytosine and Benign Neoplasms
Article | Year |
---|---|
Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?
Topics: 5-Methylcytosine; Animals; DNA Methylation; Epigenesis, Genetic; Humans; Mixed Function Oxygenases; Neoplasms; Proto-Oncogene Proteins | 2021 |
DNA Hydroxymethylation in Smoking-Associated Cancers.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Methylation; Epigenesis, Genetic; Mammals; Neoplasms; Proto-Oncogene Proteins; Smoking | 2022 |
Role of main RNA modifications in cancer: N
Topics: 5-Methylcytosine; Adenosine; Humans; Neoplasms; Pseudouridine; RNA Processing, Post-Transcriptional; RNA, Untranslated | 2022 |
Epigenetic Modification of Cytosines in Hematopoietic Differentiation and Malignant Transformation.
Topics: 5-Methylcytosine; Animals; Cell Differentiation; Cell Transformation, Neoplastic; Cytosine; Dioxygenases; DNA; DNA Methylation; Epigenesis, Genetic; Hematologic Diseases; Humans; Mammals; Neoplasms | 2023 |
The DNA methylation landscape in cancer.
Topics: 5-Methylcytosine; Animals; DNA; DNA Methylation; Epigenomics; Humans; Neoplasms | 2019 |
Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; DNA Methylation; Epigenesis, Genetic; Humans; Neoplasms | 2020 |
The role of m
Topics: 5-Methylcytosine; Adenosine; Humans; Neoplasms; Pseudouridine; RNA; RNA Processing, Post-Transcriptional | 2021 |
Roles and Regulations of TET Enzymes in Solid Tumors.
Topics: 5-Methylcytosine; Antineoplastic Combined Chemotherapy Protocols; Carcinogenesis; Clinical Trials as Topic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Drug Synergism; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Mixed Function Oxygenases; Mutation; Neoplasms; Proto-Oncogene Proteins; Treatment Outcome | 2021 |
RNA 5-methylcytosine modification and its emerging role as an epitranscriptomic mark.
Topics: 5-Methylcytosine; Animals; Humans; Neoplasms; Nervous System Diseases; Protein Biosynthesis; RNA Processing, Post-Transcriptional; Transcriptome | 2021 |
The role of 5-hydroxymethylcytosine in development, aging and age-related diseases.
Topics: 5-Methylcytosine; Aging; Animals; Cell Differentiation; Cytosine; DNA Methylation; Epigenesis, Genetic; Humans; Neoplasms; Oxidation-Reduction | 2017 |
Dynamic DNA methylation: In the right place at the right time.
Topics: 5-Methylcytosine; Aging; Animals; Disease; DNA Methylation; Gene Editing; Gene Expression Regulation, Developmental; Humans; Memory; Neoplasms; Single-Cell Analysis; Transcription Factors; Transcription, Genetic | 2018 |
Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cell-Free Nucleic Acids; Epigenomics; Humans; Liquid Biopsy; Neoplasms; Precision Medicine | 2019 |
[Role of 5-hydroxymethylcytosine and TET proteins in epigenetic regulation of gene expression].
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Hematopoiesis; Humans; Mixed Function Oxygenases; Neoplasms; Proto-Oncogene Proteins | 2013 |
Advances in understanding the coupling of DNA base modifying enzymes to processes involving base excision repair.
Topics: 5-Methylcytosine; Animals; Cell Differentiation; DNA; DNA Damage; DNA Glycosylases; DNA Methylation; DNA Repair; Epigenesis, Genetic; Histones; Humans; Methylation; Neoplasms; Purines; Pyrimidines | 2013 |
TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine.
Topics: 5-Methylcytosine; Animals; Cytosine; Dioxygenases; DNA; DNA Methylation; DNA Repair; Humans; Models, Biological; Mutagenesis; Neoplasms; Oxidation-Reduction | 2014 |
TET enzymes, TDG and the dynamics of DNA demethylation.
Topics: 5-Methylcytosine; Animals; Blastocyst; Cellular Reprogramming; Cytosine; DNA Methylation; DNA Repair; DNA Replication; Humans; Neoplasms; Oxidation-Reduction; Thymine DNA Glycosylase | 2013 |
5-hydroxymethylcytosine: a new insight into epigenetics in cancer.
Topics: 5-Methylcytosine; Animals; Brain Neoplasms; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Humans; Leukemia; Mixed Function Oxygenases; Neoplasms; Proto-Oncogene Proteins | 2014 |
5-hydroxymethylcytosine profiling as an indicator of cellular state.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cytosine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Models, Genetic; Neoplasms; Organ Specificity; Signal Transduction | 2013 |
The role of TET family proteins and 5-hydroxymethylcytosine in human tumors.
Topics: 5-Methylcytosine; Cell Transformation, Neoplastic; Cytosine; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Humans; Neoplasms | 2014 |
The role of 5-hydroxymethylcytosine in human cancer.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; DNA, Neoplasm; Humans; Neoplasms; Oxidation-Reduction | 2014 |
Playing TETris with DNA modifications.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation; Humans; Neoplasms; Neurodegenerative Diseases; Oxidation-Reduction; Signal Transduction | 2014 |
Mechanism and function of oxidative reversal of DNA and RNA methylation.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA; DNA Methylation; Escherichia coli; Gene Expression Regulation; Genome; Germ Cells; HEK293 Cells; Humans; Methylation; Mice; Neoplasms; Oxygen; RNA; Stem Cells; Transcriptome | 2014 |
Connections between TET proteins and aberrant DNA modification in cancer.
Topics: 5-Methylcytosine; Azacitidine; Cytosine; Decitabine; Dioxygenases; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Hematologic Neoplasms; Humans; Isocitrate Dehydrogenase; Mixed Function Oxygenases; Molecular Targeted Therapy; Mutation; Neoplasms; Proto-Oncogene Proteins; Small Molecule Libraries | 2014 |
Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
Topics: 5-Methylcytosine; Animals; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Humans; Mixed Function Oxygenases; Neoplasms; Oxidation-Reduction; Proto-Oncogene Proteins | 2014 |
5-hydroxymethylcytosine: a potential therapeutic target in cancer.
Topics: 5-Methylcytosine; Animals; Antineoplastic Agents; Cytosine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Humans; Neoplasms | 2014 |
5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Humans; Isocitrate Dehydrogenase; Mutation; Neoplasms; Proto-Oncogene Proteins | 2015 |
Hydroxymethylation and its potential implication in DNA repair system: A review and future perspectives.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Repair; Humans; Mental Disorders; Neoplasms; Neurodegenerative Diseases | 2015 |
5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy.
Topics: 5-Methylcytosine; Cytosine; Dioxygenases; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Binding Proteins; Humans; Isocitrate Dehydrogenase; Neoplasms; Proto-Oncogene Proteins | 2015 |
[TET proteins and epigenetic modifications in cancers].
Topics: 5-Methylcytosine; Dioxygenases; DNA-Binding Proteins; Epigenesis, Genetic; Genetic Predisposition to Disease; Histones; Humans; Mixed Function Oxygenases; Mutation; Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins | 2015 |
Portraits of TET-mediated DNA hydroxymethylation in cancer.
Topics: 5-Methylcytosine; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation; Humans; Mixed Function Oxygenases; Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins | 2016 |
Physiological and pathological implications of 5-hydroxymethylcytosine in diseases.
Topics: 5-Methylcytosine; CpG Islands; Dioxygenases; DNA (Cytosine-5-)-Methyltransferases; DNA Demethylation; DNA Methylation; DNA-Binding Proteins; Embryonic Development; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Mixed Function Oxygenases; Neoplasms; Nervous System Diseases; Promoter Regions, Genetic; Proto-Oncogene Proteins | 2016 |
The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development.
Topics: 5-Methylcytosine; Animals; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Neoplasms; Nerve Tissue Proteins; Neurogenesis; Neurons; Protein Conformation; Signal Transduction; Structure-Activity Relationship | 2016 |
Decreased 5-hydroxymethylcytosine levels correlate with cancer progression and poor survival: a systematic review and meta-analysis.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; Humans; Lymphatic Metastasis; Neoplasms; Prognosis | 2017 |
The application of genome-wide 5-hydroxymethylcytosine studies in cancer research.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; DNA Methylation; Epigenesis, Genetic; Humans; Neoplasms; Sequence Analysis, DNA | 2017 |
5-Hydroxymethylcytosine, the sixth base of the genome.
Topics: 5-Methylcytosine; Animals; Bacteriophages; Cell Differentiation; Central Nervous System; Chromatography, Liquid; Cytosine; DNA; DNA Methylation; DNA, Viral; Epigenesis, Genetic; Female; Genome; Humans; Male; Mass Spectrometry; Neoplasms; Pluripotent Stem Cells | 2011 |
[Cytosine methylation in DNA and its role in cancer therapy].
Topics: 5-Methylcytosine; Animals; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; Neoplasms | 2011 |
DNA methylation testing and marker validation using PCR: diagnostic applications.
Topics: 5-Methylcytosine; Biomarkers; Cell Differentiation; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Germ Cells; Humans; Molecular Diagnostic Techniques; Neoplasms; Polymerase Chain Reaction | 2012 |
Tet family proteins and 5-hydroxymethylcytosine in development and disease.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Methylation; DNA-Binding Proteins; Embryonic Development; Epigenesis, Genetic; Humans; Mice; Mice, Knockout; Molecular Structure; Multigene Family; Neoplasms; Oxidation-Reduction; Protein Structure, Tertiary; Proto-Oncogene Proteins | 2012 |
[Oxidation and deamination of nucleobases as an epigenetic tool].
Topics: 5-Methylcytosine; Animals; Base Composition; Chromatin Assembly and Disassembly; Cytosine; Deamination; DNA; DNA Methylation; DNA-Binding Proteins; Epigenomics; Gene Expression Regulation; Guanine; Mutation; Neoplasms; Oxidation-Reduction; Sequence Analysis, DNA; Transcription, Genetic | 2012 |
Cancer genetics and epigenetics: two sides of the same coin?
Topics: 5-Methylcytosine; DNA Methylation; DNA Repair; Epigenesis, Genetic; Humans; MicroRNAs; Neoplasms; Point Mutation; Signal Transduction | 2012 |
Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.
Topics: 5-Methylcytosine; Animals; Cell Differentiation; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Embryonic Development; Humans; Neoplasms; Proto-Oncogene Proteins | 2013 |
Cytosine methylation and DNA repair.
Topics: 5-Methylcytosine; Animals; Bacteria; CpG Islands; Cytosine; Dealkylation; Deamination; DNA Glycosylases; DNA Methylation; DNA Repair; DNA Replication; Humans; Mutagens; Neoplasms | 2006 |
5-methylcytosine, gene regulation, and cancer.
Topics: 5-Methylcytosine; Animals; Azacitidine; Base Sequence; Carcinogens; Cell Transformation, Neoplastic; Cytosine; DNA (Cytosine-5-)-Methyltransferases; DNA Replication; Fibroblasts; Gene Expression Regulation; Humans; Models, Biological; Muscles; Neoplasms; Oncogenes | 1983 |
5-Methylcytosine depletion during tumour development: an extension of the miscoding concept.
Topics: 5-Methylcytosine; Alkylation; Amino Acid Metabolism, Inborn Errors; Animals; Carcinogens; Cell Transformation, Neoplastic; Choline Deficiency; Cytosine; DNA; DNA Repair; Gene Expression Regulation; Humans; Methylation; Methyltransferases; Models, Genetic; Neoplasms; Oncogenes; Rats; Tyrosine; Vitamin B 6 Deficiency | 1983 |
DNA methylation and mutation.
Topics: 5-Methylcytosine; Animals; Base Composition; Cytosine; Dinucleoside Phosphates; DNA; DNA Repair; Humans; Methylation; Mutation; Neoplasms | 1993 |
Spontaneous mutations and fidelogens.
Topics: 5-Methylcytosine; Animals; Antimutagenic Agents; Apurinic Acid; Cytosine; DNA Repair; DNA Replication; Escherichia coli; Free Radicals; Humans; Mutation; Neoplasms; Recombination, Genetic; Saccharomyces cerevisiae | 1993 |
DNA methylation and cancer.
Topics: 5-Methylcytosine; Animals; Cytosine; Dinucleoside Phosphates; DNA; DNA Repair; Genes, p53; Genes, Tumor Suppressor; Humans; Methylation; Mutagens; Mutation; Neoplasms; Transcription, Genetic | 1993 |
The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene.
Topics: 5-Methylcytosine; Cytosine; DNA, Neoplasm; Genes, p53; Humans; Mutation; Neoplasms; Tumor Suppressor Protein p53 | 1996 |
DNA methylation and polyamines in embryonic development and cancer.
Topics: 5-Methylcytosine; Animals; Cell Transformation, Neoplastic; Cytosine; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Replication; Embryonic and Fetal Development; Female; Gene Expression Regulation, Developmental; Humans; Male; Methylation; Mice; Mutagenesis; Neoplasms; Nucleic Acid Conformation; Oogenesis; Polyamines; Replication Origin; Spermatogenesis; Transcription, Genetic | 1995 |
DNA methylation errors and cancer.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Imprinting, Psychological; Methylation; Mutation; Neoplasms | 1996 |
Mechanisms of spontaneous human cancers.
Topics: 5-Methylcytosine; CpG Islands; Cytosine; Disease Susceptibility; DNA Damage; Environmental Exposure; Humans; Mutation; Neoplasms; Oxidation-Reduction; Risk Factors; Smoking | 1996 |
The relationship of DNA methylation to cancer.
Topics: 5-Methylcytosine; Azacitidine; CpG Islands; Cytosine; Decitabine; DNA Methylation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Methyltransferases; Neoplasms | 1996 |
Mutagenic and epigenetic effects of DNA methylation.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Methylation; Enzymes; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Mutation; Neoplasms; Transcription, Genetic; Uracil | 1997 |
Altered DNA methylation and genome instability: a new pathway to cancer?
Topics: 5-Methylcytosine; Animals; Cytosine; DNA Methylation; DNA, Neoplasm; Genes, Tumor Suppressor; Humans; Mice; Neoplasms; Promoter Regions, Genetic | 1997 |
DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis.
Topics: 5-Methylcytosine; Alkylating Agents; Animals; Cytosine; DNA Damage; DNA Methylation; DNA Modification Methylases; DNA Repair; Enzyme Inhibitors; Humans; Mutation; Neoplasms; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; Topoisomerase II Inhibitors | 1997 |
Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis.
Topics: 5-Methylcytosine; Alleles; Animals; Cell Differentiation; Chromatin; CpG Islands; Cytosine; DNA Methylation; DNA, Neoplasm; Gene Expression Regulation; Gene Expression Regulation, Developmental; Humans; Mutation; Neoplasms; S-Adenosylmethionine | 1997 |
Oncogenic mechanisms mediated by DNA methylation.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA; DNA Methylation; Humans; Mammals; Mutation; Neoplasms; Nucleic Acid Conformation; Oncogenes | 1997 |
Mutagenesis in the P53 gene.
Topics: 5-Methylcytosine; Carcinogens, Environmental; Cytosine; DNA Damage; Genes, p53; Humans; Mutagens; Mutation; Neoplasms | 1997 |
Dynamic interrelationships between DNA replication, methylation, and repair.
Topics: 5-Methylcytosine; Animals; Chromatin; CpG Islands; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytosine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Repair; DNA Replication; DNA, Neoplasm; Gene Expression Regulation; Humans; Models, Genetic; Mutation; Neoplasm Proteins; Neoplasms; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53 | 1997 |
Formation and repair of DNA lesions in the p53 gene: relation to cancer mutations?
Topics: 5-Methylcytosine; Animals; Benzo(a)pyrene; Breast Neoplasms; Carcinogens, Environmental; Colonic Neoplasms; Cytosine; Deamination; DNA Adducts; DNA Damage; DNA Mutational Analysis; DNA Repair; Genes, p53; Humans; Lung Neoplasms; Mice; Mutagenesis; Neoplasms; Neoplasms, Radiation-Induced; Selection, Genetic; Skin Neoplasms; Smoking; Tumor Suppressor Protein p53; Ultraviolet Rays | 1998 |
DNA methylation: past, present and future directions.
Topics: 5-Methylcytosine; Antimetabolites, Antineoplastic; Azacitidine; Carcinogens; Chromatin; Cytosine; DNA Methylation; DNA Repair; Forecasting; Gene Expression; Humans; Neoplasms | 2000 |
Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications.
Topics: 5-Methylcytosine; Acetylation; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; CpG Islands; Cytosine; DNA Methylation; Fetal Hemoglobin; Gene Expression Regulation, Neoplastic; Hematologic Diseases; Histones; Humans; Methylation; Neoplasms | 2001 |
Methylation matters.
Topics: 5-Methylcytosine; Chromosome Aberrations; CpG Islands; Cytosine; DNA Methylation; DNA Transposable Elements; Gene Expression Regulation, Neoplastic; Genomics; Humans; Neoplasms; Oncogenes; Syndrome | 2001 |
Methylation, mutation and cancer.
Topics: 5-Methylcytosine; Animals; Cell Transformation, Neoplastic; Cytosine; Deamination; DNA; DNA, Neoplasm; Female; Genes, p53; Genetic Diseases, Inborn; Humans; Male; Methylation; Mutation; Neoplasms; Neoplasms, Experimental; Vertebrates | 1992 |
5-Methylcytosine as an endogenous mutagen in the p53 tumor suppressor gene.
Topics: 5-Methylcytosine; Animals; Cytosine; DNA; Genes, p53; Humans; Mutagens; Mutation; Neoplasms | 1991 |
Hypomethylation of DNA in the regulation of gene expression.
Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Differentiation; Cytosine; DNA; Gene Expression Regulation; Humans; Methylation; Methyltransferases; Neoplasms | 1988 |
52 other study(ies) available for 5-methylcytosine and Benign Neoplasms
Article | Year |
---|---|
Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
Topics: 5-Methylcytosine; Cell-Free Nucleic Acids; Disease Progression; Early Detection of Cancer; Humans; Neoplasms; RNA, Long Noncoding | 2021 |
BiLSTM-5mC: A Bidirectional Long Short-Term Memory-Based Approach for Predicting 5-Methylcytosine Sites in Genome-Wide DNA Promoters.
Topics: 5-Methylcytosine; Aging; Deep Learning; DNA; DNA Methylation; Humans; Memory, Short-Term; Neoplasms; Promoter Regions, Genetic | 2021 |
5-Hydroxymethylcytosine (5hmC) at or near cancer mutation hot spots as potential targets for early cancer detection.
Topics: 5-Methylcytosine; DNA; DNA Methylation; Humans; Mutation; Neoplasms | 2022 |
Hydroxymethylation-Specific Ligation-Mediated Single Quantum Dot-Based Nanosensors for Sensitive Detection of 5-Hydroxymethylcytosine in Cancer Cells.
Topics: 5-Methylcytosine; Animals; Biotin; DNA; DNA Methylation; Mammals; Neoplasms; Quantum Dots | 2022 |
Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules.
Topics: 5-Methylcytosine; DNA; DNA Copy Number Variations; DNA Methylation; Female; Humans; Methylation; Mutation; Neoplasms | 2023 |
Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins.
Topics: 5-Methylcytosine; Animals; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Fibroblasts; Leukemia; Mice; Mitoxantrone; Neoplasms | 2023 |
In silico structural analysis of sequences containing 5-hydroxymethylcytosine reveals its potential as binding regulator for development, ageing and cancer-related transcription factors.
Topics: 5-Methylcytosine; Aging; DNA Methylation; G-Quadruplexes; Humans; Neoplasms; Transcription Factors | 2021 |
Pan-cancer analysis of m
Topics: 5-Methylcytosine; DNA Copy Number Variations; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, Regulator; Humans; Mutation; Neoplasms; Prognosis | 2021 |
The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.
Topics: 5-Methylcytosine; Colorectal Neoplasms; CpG Islands; DNA Methylation; DNA Mismatch Repair; DNA Polymerase II; DNA Repair; DNA Replication; Genes, APC; Genes, Neoplasm; Genes, p53; Genome, Human; Humans; Microsatellite Instability; Mutation; Neoplasms; Poly-ADP-Ribose Binding Proteins | 2017 |
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
Topics: 5-Methylcytosine; Adult; Aged; Animals; Cell-Free Nucleic Acids; Circulating Tumor DNA; Cytosine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms | 2017 |
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Biomarkers, Tumor; Cell-Free Nucleic Acids; Circulating Tumor DNA; DNA Methylation; Epigenomics; Female; Gene Expression Regulation, Neoplastic; Humans; Liquid Biopsy; Male; Middle Aged; Neoplasms; Young Adult | 2017 |
Integrating DNA Methylation and Hydroxymethylation Data with the Mint Pipeline.
Topics: 5-Methylcytosine; Computational Biology; DNA Methylation; Epigenesis, Genetic; High-Throughput Nucleotide Sequencing; Humans; Immunoprecipitation; Neoplasms; Software | 2017 |
DNA Replication and associated repair pathways are involved in the mutagenesis of methylated cytosine.
Topics: 5-Methylcytosine; Carcinogenesis; CpG Islands; DNA Mismatch Repair; DNA Polymerase II; DNA Replication; Humans; Mutagenesis; Neoplasms | 2018 |
Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.
Topics: 5-Methylcytosine; Alleles; Base Sequence; Cell Line, Tumor; CpG Islands; DNA; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Histone Code; Humans; Mutation; Neoplasms; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Protein Binding; Survival Analysis; Telomerase; Transcription, Genetic | 2017 |
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Survival; Dioxygenases; DNA-Binding Proteins; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Knockdown Techniques; Humans; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasms; Proto-Oncogene Proteins; Recurrence; Xenograft Model Antitumor Assays | 2018 |
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer.
Topics: 5-Methylcytosine; Adenylate Kinase; Animals; Diabetes Mellitus; Dioxygenases; DNA; DNA Methylation; DNA-Binding Proteins; Enzyme Stability; Epigenesis, Genetic; Glucose; Glycated Hemoglobin; Humans; Hyperglycemia; Metformin; Mice; Mice, Nude; Neoplasms; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins; Substrate Specificity; Xenograft Model Antitumor Assays | 2018 |
Gene body profiles of 5-hydroxymethylcytosine: potential origin, function and use as a cancer biomarker.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Genome; Humans; Neoplasms | 2018 |
Epigenetic control by sugar.
Topics: 5-Methylcytosine; Diabetes Mellitus; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Glucose; Humans; Neoplasms; Proto-Oncogene Proteins | 2018 |
Sensitive detection of hydroxymethylcytosine levels in normal and neoplastic cells and tissues.
Topics: 5-Methylcytosine; Animals; Cell Dedifferentiation; DNA Methylation; Electrophoresis, Capillary; Fluorescence; Glioma; Humans; Lung Neoplasms; Mice; Neoplasms | 2019 |
DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.
Topics: 5-Methylcytosine; Animals; Cell Line, Tumor; CpG Islands; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Histones; Humans; Male; Methylation; Mice, Inbred C57BL; Mice, Knockout; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Promoter Regions, Genetic | 2019 |
Statistical methods for classification of 5hmC levels based on the Illumina Inifinium HumanMethylation450 (450k) array data, under the paired bisulfite (BS) and oxidative bisulfite (oxBS) treatment.
Topics: 5-Methylcytosine; Case-Control Studies; DNA Methylation; Humans; Neoplasms; Oxidation-Reduction; Sulfites | 2019 |
5-Hydroxymethylcytosine as a clinical biomarker: Fluorescence-based assay for high-throughput epigenetic quantification in human tissues.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cost-Benefit Analysis; Epigenesis, Genetic; Fluorescence; High-Throughput Screening Assays; Humans; Mice; Neoplasms; Proof of Concept Study | 2020 |
Tight correlation of 5-hydroxymethylcytosine and Polycomb marks in health and disease.
Topics: 5-Methylcytosine; Cell Differentiation; Cell Line, Tumor; Cytosine; DNA Methylation; Epigenomics; Female; Histones; Humans; In Vitro Techniques; Male; Neoplasms; Polycomb-Group Proteins | 2013 |
The degree of global DNA hypomethylation in peripheral blood correlates with that in matched tumor tissues in several neoplasia.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brain Neoplasms; DNA Methylation; Epigenesis, Genetic; Female; Humans; Male; Middle Aged; Neoplasms; Young Adult | 2014 |
Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Blood Chemical Analysis; Cells, Cultured; DNA Methylation; Enzyme-Linked Immunosorbent Assay; Folic Acid; Genes, Neoplasm; Humans; Microscopy, Confocal; Neoplasms; Neoplastic Cells, Circulating; Surface Properties; Survival Analysis | 2014 |
Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A.
Topics: 5-Methylcytosine; Basic Helix-Loop-Helix Transcription Factors; Cell Cycle Proteins; Cell Line, Tumor; CpG Islands; Cytosine; DNA Methylation; DNA Repair; Gene Expression Regulation, Neoplastic; Genome, Human; HEK293 Cells; Humans; Molecular Sequence Data; Neoplasms; Nuclear Proteins; Promoter Regions, Genetic; RNA, Long Noncoding; Thymine DNA Glycosylase | 2014 |
Decrease of 5-hydroxymethylcytosine in rat liver with subchronic exposure to genotoxic carcinogens riddelliine and aristolochic acid.
Topics: 5-Methylcytosine; Animals; Aristolochic Acids; Carcinogenesis; Carcinogens; Cytosine; DNA-Binding Proteins; Epigenesis, Genetic; Liver; Mutation; Neoplasms; Pyrrolizidine Alkaloids; Rats; Rats, Inbred F344; Rats, Transgenic | 2015 |
Quantification of 5-methylcytosine, 5-hydroxymethylcytosine and 5-carboxylcytosine from the blood of cancer patients by an enzyme-based immunoassay.
Topics: 5-Methylcytosine; Cytosine; DNA; Epigenesis, Genetic; Humans; Immunoenzyme Techniques; Limit of Detection; Neoplasms | 2014 |
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.
Topics: 5-Methylcytosine; Basic Helix-Loop-Helix Transcription Factors; Catalytic Domain; Cell Hypoxia; Cell Line, Tumor; DNA-Binding Proteins; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mixed Function Oxygenases; Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins | 2014 |
CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer.
Topics: 5-Methylcytosine; Animals; Cell Death; Cell Line, Tumor; Cytidine; Cytidine Deaminase; Cytosine; Deoxycytidine; DNA; DNA Damage; DNA-Directed DNA Polymerase; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasms; Nucleotides; Oxidation-Reduction; Phosphotransferases; Substrate Specificity; Up-Regulation; Uridine | 2015 |
Development-linked changes in DNA methylation and hydroxymethylation in humans: interview with Dr Melanie Ehrlich.
Topics: 5-Methylcytosine; DNA Methylation; Epigenesis, Genetic; Epigenomics; History, 20th Century; History, 21st Century; Humans; Methylation; Neoplasms; Organ Specificity | 2015 |
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy.
Topics: 5-Methylcytosine; Alternative Splicing; Animals; Cell Line, Tumor; Cytosine; Epigenesis, Genetic; Gene Amplification; Humans; Methyl-CpG-Binding Protein 2; Mice; Neoplasm Transplantation; Neoplasms; Protein Isoforms; ras Proteins; Signal Transduction | 2016 |
The decreased N
Topics: 3T3-L1 Cells; 5-Methylcytosine; Adenine; Animals; Chromatography, High Pressure Liquid; DNA; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms; Tandem Mass Spectrometry | 2016 |
Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver.
Topics: 5-Methylcytosine; CpG Islands; DNA; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation; Humans; Liver; Lung; Neoplasms; Organ Specificity; Promoter Regions, Genetic; Whole Genome Sequencing | 2016 |
Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lymphocytes; Lymphoid Progenitor Cells; Neoplasm Grading; Neoplasms; Promoter Regions, Genetic; Protein Transport; Ubiquitin-Protein Ligases | 2016 |
Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress.
Topics: 5-Methylcytosine; Acetylation; Chromatin; Dioxygenases; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Binding Proteins; DNA, Neoplasm; E1A-Associated p300 Protein; HCT116 Cells; Histone Deacetylase 1; Histone Deacetylase 2; Humans; Neoplasms; Oxidative Stress; Protein Binding; Protein Processing, Post-Translational; Protein Stability; Proto-Oncogene Proteins; RNA Interference; Time Factors; Transfection; Ubiquitination | 2017 |
5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.
Topics: 5-Methylcytosine; Animals; Base Sequence; Brain; Brain Neoplasms; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, Liquid; Cytosine; DNA-Binding Proteins; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Lung Neoplasms; Male; Mice; Mixed Function Oxygenases; Molecular Structure; Mutation; Neoplasms; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
Topics: 5-Methylcytosine; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Cytosine; DNA Methylation; DNA-Binding Proteins; Gene Knockdown Techniques; Humans; Mixed Function Oxygenases; Mutation; Neoplasms; Proto-Oncogene Proteins; Stomach Neoplasms | 2012 |
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cell Transformation, Neoplastic; Cytosine; Dioxygenases; DNA-Binding Proteins; Down-Regulation; Humans; Hydroxylation; Mice; Mixed Function Oxygenases; Neoplasms; Proto-Oncogene Proteins | 2013 |
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
Topics: 5-Methylcytosine; 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adenocarcinoma; Breast Neoplasms; Colorectal Neoplasms; CpG Islands; Cystathionine beta-Synthase; Cytosine; DNA Methylation; DNA, Neoplasm; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Lung Neoplasms; Methylenetetrahydrofolate Reductase (NADPH2); Neoplasms; Oxidoreductases Acting on CH-NH Group Donors | 2002 |
Cellular vitamins, DNA methylation and cancer risk.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; Humans; Immunohistochemistry; Neoplasms; Risk Factors; Vitamins | 2002 |
A systematic profile of DNA methylation in human cancer cell lines.
Topics: 5-Methylcytosine; Azacitidine; Cluster Analysis; CpG Islands; Cytosine; Decitabine; DNA Methylation; DNA, Neoplasm; Genes, Tumor Suppressor; Germ-Line Mutation; Humans; Neoplasms; Oligonucleotide Array Sequence Analysis; Tumor Cells, Cultured | 2003 |
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.
Topics: 5-Methylcytosine; Amino Acid Sequence; Breast Neoplasms; Chromatin; Chromosomal Proteins, Non-Histone; Chromosome Mapping; CpG Islands; DNA Methylation; DNA-Binding Proteins; Female; Humans; Methyl-CpG-Binding Protein 2; Microscopy, Confocal; Molecular Sequence Data; Neoplasms; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Peptide Fragments; Polymerase Chain Reaction; Promoter Regions, Genetic; Repressor Proteins; Tumor Cells, Cultured | 2003 |
Determination of 5-methyl-cytosine and cytosine in tumor DNA of cancer patients.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; DNA, Neoplasm; Electrophoresis, Capillary; Humans; Neoplasms; Reproducibility of Results | 2005 |
FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Topics: 5-Methylcytosine; Amination; Cell Cycle Proteins; Dinucleotide Repeats; DNA Methylation; F-Box Proteins; F-Box-WD Repeat-Containing Protein 7; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Models, Molecular; Mutation; Neoplasms; Protein Isoforms; Substrate Specificity; Ubiquitin-Protein Ligases | 2007 |
The 5-methylcytosine content of DNA from human tumors.
Topics: 5-Methylcytosine; Brain Chemistry; Cytosine; DNA; DNA Restriction Enzymes; DNA, Neoplasm; Female; Humans; Methylation; Neoplasms; Placenta; Pregnancy; Structure-Activity Relationship | 1983 |
Extent of DNA methylation in human tumor cells.
Topics: 5-Methylcytosine; Base Composition; Cell Line; Chromatography, High Pressure Liquid; Cytosine; DNA; DNA (Cytosine-5-)-Methyltransferases; Gene Expression Regulation; Humans; Methylation; Methyltransferases; Neoplasms | 1983 |
Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants.
Topics: 5-Methylcytosine; Autoradiography; Cell Line; Cerebellar Neoplasms; Cytosine; DNA; Fibroblasts; Humans; Medulloblastoma; Neoplasms; Neuroblastoma; Retinoblastoma | 1983 |
A cytosine methyltransferase converts 5-methylcytosine in DNA to thymine.
Topics: 5-Methylcytosine; Cytosine; DNA; DNA-Cytosine Methylases; Escherichia coli; Humans; Methylation; Molecular Structure; Mutagenesis; Neoplasms; S-Adenosylhomocysteine; S-Adenosylmethionine; Thymine | 1995 |
Methylation and p16: suppressing the suppressor.
Topics: 5-Methylcytosine; Carrier Proteins; Cell Transformation, Neoplastic; Cocarcinogenesis; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Cytosine; DNA; Gene Expression Regulation; Genes, Tumor Suppressor; Genomic Imprinting; Humans; Methylation; Models, Genetic; Neoplasms | 1995 |
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
Topics: 5-Methylcytosine; Alleles; Azacitidine; Base Sequence; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carrier Proteins; Chromosomes, Human, Pair 9; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Cytosine; Decitabine; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Methylation; Molecular Sequence Data; Neoplasm Proteins; Neoplasms; Sequence Deletion; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Hypomethylation of DNA: a possible nongenotoxic mechanism underlying the role of cell proliferation in carcinogenesis.
Topics: 5-Methylcytosine; Animals; Cell Division; Cytosine; DNA; Female; Liver Neoplasms, Experimental; Male; Methylation; Mice; Neoplasms; Proto-Oncogenes | 1993 |